Figure 11. Immunohistochemistry for (A) DTX1 (https://www.proteinatlas.org/ENSG00000135144-DTX1/pathology/breast+cancer#imid_18106719). (B) FEZ1 (https://www.proteinatlas.org/ENSG00000149557-FEZ1/pathology/breast+cancer#imid_20550866). (C) FXYD3 (https://www.proteinatlas.org/ENSG00000089356-FXYD3/pathology/breast+cancer#imid_3109719). (D) FOXJ1 (https://www.proteinatlas.org/ENSG00000129654-FOXJ1/pathology/breast+cancer#imid_18961115). (E) HOXC13 (https://www.proteinatlas.org/ENSG00000123364-HOXC13/pathology/breast+cancer#imid_15073368). (F) LEF1 (https://www.proteinatlas.org/ENSG00000138795-LEF1/pathology/breast+cancer#imid_913343). (G) MMP25 (https://www.proteinatlas.org/ENSG00000008516-MMP25/pathology/breast+cancer#imid_9651206). (H) NFE2 (https://www.proteinatlas.org/ENSG00000123405-NFE2/pathology/breast+cancer#imid_927392). (I) NRG1 (https://www.proteinatlas.org/ENSG00000157168-NRG1/pathology/breast+cancer#imid_3118350). (J) SCG2 (https://www.proteinatlas.org/ENSG00000171951-SCG2/pathology/breast+cancer#imid_20497272). (K) TP63 (https://www.proteinatlas.org/ENSG00000073282-TP63/pathology/breast+cancer#imid_143251). (L) ULBP2 (https://www.proteinatlas.org/ENSG00000131015-ULBP2/pathology/breast+cancer#imid_5232353).